FDA has announced proposed product standards that would prohibit menthol as a characterizing flavor in cigarettes and prohibit all characterizing flavors other than tobacco in cigars.
MD Anderson, Community Health Network announce partnership to create fully integrated cancer program
The University of Texas MD Anderson Cancer Center and Indianapolis-based Community Health Network announced a partnership agreement to create Community Health Network MD Anderson Cancer Center.
Shelley Johns was named the Walther Scholar in Psycho-Oncology at Indiana University School of Medicine.
UC Davis Comprehensive Cancer Center is launching the Center for Advancing Cancer Health Equity, which will conduct community-engaged research and interventions.
The American Cancer Society and St. Baldrick’s Foundation recently awarded $1.2 million in a second round of Pilot Accelerator grants requiring researchers to use clinical trials to accelerate treatment options for childhood cancer.
The American Society for Transplantation and Cellular Therapy presented awards to researchers in the field of transplantation and cellular therapy at the tandem meetings of ASTCT and the Center for International Blood and Marrow Transplant Research.
Independence Blue Cross and the Colorectal Cancer Alliance announced a cancer screening and prevention program which aims to address the decrease in colorectal cancer screening rates among Black Philadelphians since the pandemic started.
Stand Up To Cancer appointed five new members to the SU2C Health Equity Committee. SU2C established the Health Equity Committee in 2018, a year after it began developing its Health Equity Initiative. The initiative was formally announced in 2020.
The phase II COAST clinical trial demonstrated improved outcomes using immunotherapy combinations for patients with unresectable stage III non-small cell lung cancer, according to researchers at Yale Cancer Center, Cancer Center of Kansas, University of Colorado, Abramson Cancer Center, Astrazenaca, and collaborating international organizations.
The American Society of Clinical Oncology published an update expanding the utility of Breast Cancer Index, developed by Hologic Inc., within its Clinical Practice Guideline, “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.”
